Aarhus University Seal / Aarhus Universitets segl
Drawing of bear by Miya

Organizing committee

Sigurður Holmar Jóhannesson
Representative of the AHC Association of Iceland, mail: ahc@ahc.is

Karin Lykke-Hartmann,
Associate professor, Aarhus University, Denmark, mail: kly@biomed.au.dk

Hanne Poulsen,
Associate professor, Aarhus University, Denmark, mail: hp@mbg.au.dk

Poul Nissen,
Professor, Aarhus University, Denmark, mail: pn@mbg.au.dk

Hendrik Rosewich,
Assistant professor, Georg August University, Göttingen, Germany, mail: hendrik.rosewich@med.uni-goettingen.de

Arn M.J.M van den Maagdenberg,
Professor, Leiden University, Netherlands, mail: A.M.J.M.van_den_Maagdenberg@lumc.nl

The 8th Annual Symposium on ATP1A3 in Disease

3-4 October 2019
Reykjavík, Iceland

The 8th Annual Symposium on ATP1A3 in Disease 2019 will take place 3 - 4 October 2019 at the beautiful and conveniently located Grand Hotel Reykjavík on Iceland.

The host this year is the AHC Association of Iceland supported by an organizing committee that consist of European scientists that have been working on ATP1A3 related diseases for many years.

The ‘ATP1A3 Symposium in Disease’ is an important symposium that focuses on one of the key genes, the ATP1A3 gene that is essential for normal brain functioning. Mutations in the ATP1A3 gene has been linked to several neurological diseases, including Alternating Hemiplegia of Childhood (AHC)The ATP1A3 gene encodes the alpha(a)3 subunit isoform of the sodium pump, an ion pump that is present in all cells of the body and help cells to maintain correct ion balance, to support in-and outflux of molecules in the cell. In the brain, the a 3 isoform is specific to nerve cells, the neurons. In most neurons, the a 3 isoform helps to maintain the resting membrane potential and reset the ion gradient after an action potential. Doing this, the sodium pump uses energy from the cells and is the most energy-consuming ion pump in the brain. Therefore, it is not surprising that mutations that alter the function of such a vital pump, is associated with neurological diseases.

Registration is open!

 Confirmed Invited Speakers:

  • Kári Stefánsson - CEO of the company deCODE genetics, Island
  • Mohamad Mikati - Professor, Duke Institute for Brain Sciences, Durham, North Carolina
  • Steven Gray - Associate professor, University of Texas Southwestern Medical Center, Dallas, Texas
  • Kathryn Swoboda - Professor, Massachusetts General Hospital, Boston, Massachusetts
  • Peter Vangheluwe - Associate professor, Katholieke Universiteit Leuven, Belgium
  • Kevin Ess - Associate professor, Vanderbilt University Medical Center, Nashville, Tennessee
  • Guangping Gao - Professor, University of Massachusetts Medical School, Worcester, Massachusetts
  • Allison Brashear - Professor, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
  • Laufey Ýr Sigurðardóttir - Child Neurologist and Epileptologist, University Hospital of Iceland, Reykjavik, Iceland
  • Helga Birgisdottir - PhD student, University of Iceland, Reykjavik, Iceland
  • Poul Nissen - Professor, Aarhus University, Aarhus, Denmark

    This year, we also have the honor of having The President of Iceland, Gudni Th. Johannesson, giving the opening speech at the symposium (if his schedule permits).

Associations & Organizations in attendance:

  • AHC Association of Iceland  - An association for patients with Alternating Hemiplegia of Childhood, and a non-profit organization offering support for affected children and their families
  • AHC Federation of Europe - Finding a treatment for Alternating Hemiplegia of Childhood

Further confirmed invited speakers will be announced soon

History of the ATP1A3 Symposium

Already since 2004, it has been known that mutations in the gene could cause a rare subtype of dystonia, the Rapid onset of Dystonia Parkinson (RDP). Since then, mutations in the ATP1A3 gene has been linked to diseases, including Alternating Hemiplegia of Childhood (AHC). Understanding the gene function will help find a treatment not only for the RDP and AHC diseases that have direct link to this gene but also to many other neurological diseases, which could will help millions of people suffering from disease such as Parkinson.

AHC is an extremely debilitating disease that causes temporary paralysis and dystonia as well as permanent mental disability, ADHD, autism and other related symptoms. Since the discovery that mutations in the ATP1A3 gene could cause AHC, researchers, parents and medical consultants join forces and formed the ATP1A3 annual symposium, to exchange advise, results and data to advance our knowledge towards a treatment.

The ‘ATP1A3 Symposium in Disease’ took a starting point in 2012, where 3 publications (in the Goldstein (doi: 10.1038/ng.2358), Gärtner (doi: 10.1016/S1474-4422(12)70182-5) and Hirose (doi: 10.1371/journal.pone.0056120) groups, including many very dedicated researchers, parents/patients and clinicians, representing people who stay active in the research field) showed that mutations in the ATP1A3 gene could cause alternating Hemiplegia of childhood (AHC), in addition to another movement disorder, Rapid onset of Dystonia (RDP), that was discovered in 2004. Since then, the genotype/phenotype of ATP1A3 and neurological diseases has proven extremely complex, and through our annual symposium meetings, we gather prominent scientists along clinicians, parents and patients to understand the disease and find a cure.  

Please see this link for our vision and previous meetings: http://www.atp1a3disease.org/

Symposium venue 2019

Grand Hotel Reykjavik

Sigtún 38
105 Reykjavik

See video presentation of Grand Hotel Reykjavík, including stunning pictures of the Icelandic nature

Note the dates

Registration and payment deadlines

Early birdApril - 31 May 2019
Standard1 June - 1 August 2019
Late2 August - 1 October 2019

Abstract submission deadline for poster & oral presentation

Abstract subm.April - 1 August 2019

Logo of Aarhus University
Logo of the AHC Association on Island